Prevention of coronary heart disease in primary medical care in Poland: results from the LIPIDOGRAM study
T Tomasik, J Jozwiak, A Windak… - European Journal of …, 2011 - academic.oup.com
Abstract Aims To determine:(1) achievement of cholesterol therapy goals in patients
receiving lipid-lowering drugs in Polish primary care between the years 2004 and 2006;(2) …
receiving lipid-lowering drugs in Polish primary care between the years 2004 and 2006;(2) …
[PDF][PDF] Prevelance of dyslipidemia and general ineffectiveness of its treatment in both primary and secondary prevention of coronary heart disease within family …
E Konduracka, J Jóźwiak, M Mastej, W Lukas… - Przegląd …, 2008 - ruj.uj.edu.pl
Purpose Despite major advances in cardiology dyslipidemia continues to be
underdiagnosed and undertreated. The study aimed to evaluate current prevalence of …
underdiagnosed and undertreated. The study aimed to evaluate current prevalence of …
[PDF][PDF] Detection and treatment of hypercholesterolemia in primary health care: results of the POLKARD program of the Ministry of Health of the Republic of Poland
M Kozela, K Szafraniec, G Broda, I Cichocka… - … = Polish Archives of …, 2012 - ruj.uj.edu.pl
AbstrAct IntroductIon About 90% of Polish adults with hypercholesterolemia are not aware of
their disease or are not treated. objectIves The aim of the study was to evaluate …
their disease or are not treated. objectIves The aim of the study was to evaluate …
Potential for cholesterol lowering in secondary prevention of coronary heart disease in Europe: findings from EUROASPIRE study
D Vanuzzo, L Pilotto, GB Ambrosio, K Pyörälä, S Lehto… - Atherosclerosis, 2000 - Elsevier
We have examined the potential for cholesterol lowering in secondary prevention of
coronary heart disease based on data from the European Action on Secondary Prevention …
coronary heart disease based on data from the European Action on Secondary Prevention …
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life …
J Ruof, G Klein, W März, H Wollschläger, A Neiss… - Preventive …, 2002 - Elsevier
Background. Few published data in particular from the United States indicate that the
implementation of guidelines for prevention of coronary heart disease (CHD) is far from …
implementation of guidelines for prevention of coronary heart disease (CHD) is far from …
Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRISK Study
E Alemao, D Yin, H Sintonen, V Salomaa… - American journal of …, 2006 - Springer
Background European and US study findings show that patients in primary care and
specialty care are not adequately treated for cholesterol reduction. Objective To evaluate …
specialty care are not adequately treated for cholesterol reduction. Objective To evaluate …
Lipid-modifying therapy and attainment of cholesterol goals in Hungary: the return on expenditure achieved for lipid therapy (REALITY) study
G Paragh, L Márk, K Zámolyi, G Pados… - Clinical drug …, 2007 - Springer
Background and objective: Cardiovascular disease is a leading cause of death in Eastern
Europe. Few studies on cholesterol goal achievement have been conducted in Hungarian …
Europe. Few studies on cholesterol goal achievement have been conducted in Hungarian …
Insufficient use of lipid-lowering drugs and measurement of serum cholesterol among patients with a history of myocardial infarction
J Larsen, M Andersen, L Bjerrum… - European Journal of …, 2003 - academic.oup.com
Background The effect of lipid-lowering drugs (LLDs) on coronary heart disease is well
documented, particularly in patients with established ischaemic heart disease. However …
documented, particularly in patients with established ischaemic heart disease. However …
LDL-cholesterol in secondary prevention: goal-attainment in patients on lipid-lowering drugs in private practice and in hospitals in Austria (ZIEL)
B Föger, JR Patsch - Wiener klinische Wochenschrift, 2011 - Springer
BACKGROUND: A hospital-based screening project (HSP) in Austria found 47% of high-risk
patients (LDL-C< 100 mg/dl) and 24% of very high-risk patients (LDL-C< 70 mg/dl) at goal …
patients (LDL-C< 100 mg/dl) and 24% of very high-risk patients (LDL-C< 70 mg/dl) at goal …
Long-term effects on cholesterol levels and the utilization of lipid-lowering drugs of a hospital-based programme for secondary prevention of coronary artery disease
M Stagmo, L Westin, R Carlsson… - Journal of …, 2001 - journals.sagepub.com
Background The study was designed to determine whether a 1-year hospital-based
secondary prevention programme would have any long-term effects on serum lipid levels …
secondary prevention programme would have any long-term effects on serum lipid levels …